Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

European Society of Reproductive Immunology Annual Meeting

Reproductive Medicine & Genetics

The 12th Conference of the European Society for Reproductive Immunology will be held at Magdalen College, Oxford from Monday 21st – Thursday 24th September 2015

Magdalen College, Oxford © Oxford University
Magdalen College, Oxford

The 12th Conference of the European Society for Reproductive Immunology will be held at Magdalen College, Oxford, from Monday 21st – Thursday 24th September 2015. The venue has a special significance for our field as Sir Peter Medawar, considered to be the founding father of Reproductive Immunology, was a student and Fellow of Magdalen. His seminal paper of 1953 has driven research in this area for the last 60 years and although our understanding has changed significantly, his ideas are still relevant today. We have put together a diverse scientific programme which reflects these new concepts and will bring you the latest developments in key areas of research.

Accommodation will be in Magdalen College and the nearby Queen‘s College. The welcome event will be held at the Pitt Rivers Museum of Archaeology and Anthropology and a traditional Oxford Gala dinner will be held at Magdalen College – not to be missed. 

The number of places is strictly limited to 160 so you are advised to book early to make sure you do not miss this very special occasion. Book now 

Latest Tweets

Communications Team

Similar stories

MitOX 2023- 21st April

The Nuffield Department of Women's & Reproductive Health invites you to MitOX 2023 on Friday 21st April. Our annual conference for researchers with an interest in mitochondria from academia and pharma. This year's event will be 'hybrid', so you can join in-person or virtually!

Award Winning Podcast

‘Unheard of – The hidden voice of Endometriosis ’ the podcast series co-hosted by Danielle Perro (Postdoctoral Researcher in Epidemiology) and Magda Mareckova (DPhil student) has been recognised by the Wellcome Centre for Human Genetics, with a Public Engagement with Research Project Award.

What is the impact of heavy menstrual bleeding on female health and well-being?

Many of us have no idea whether or not our period is “normal”. It’s no wonder, since not only is everyone different, but the stigma still keeps many of us from asking questions or discussing what we go through every month with friends and family. Principal Investigator Prof Suzannah Williams and DPhil student Tomi Adeniran explore what heavy periods can mean in their article published in The Conversation.

Women's Health Strategy for England Launched

The government has published the first ever Women's Health Strategy for England to tackle the gender health gap. Menopause, Endometriosis, Contraception and Fertility treatment are highlighted as some of the top issues women have asked for action on. The Nuffield Department of Women's & Reproductive Health welcome and fully support this bold and exciting strategy to help improve the health of millions of women in England.

Prof Christian Becker wins Clinical Science Award at ESHRE 2022

Congratulations to Professor Christian Becker who was presented with a Clinical Science Award for best oral presentation at the ESHRE 38th Annual Meeting in Milan, Italy this week.

Oxford's largest ever study into Varicose veins shows need for surgery is linked to genetics

Varicose veins are a very common manifestation of chronic venous disease, affecting over 30% of the population in Western countries. In America, chronic venous disease affects over 11 million men and 22 million women aged 40–80 years old. Left untreated it can escalate to multiple health complications including leg ulcers and ultimately amputations. A new international study by Oxford researchers published on 2nd June 2022 in Nature Communications establishes for the first time, a critical genetic risk score to predict the likelihood of patients suffering with Varicose veins to require surgery, as well as pointing the way towards potential new therapies.